| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Research &Development | SVP, Development | SVP, Development
1 company
Graham Richard A is a SVP, Research &Development at Theravance Biopharma, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,084 | $10.73 | $22,361.32 | -0.7% | -7.0% | -1.4% | |
| Aug 16, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 4,906 | $9.71 | $47,639.71 | -1.3% | +14.9% | -0.8% | |
| Aug 9, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 15,086 | $8.79 | $132,605.94 | -3.9% | +11.7% | +13.3% | |
| Dec 14, 2020 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 7,500 | $19.47 | $146,058.00 | -5.7% | - | - |